Evidence map›Paper›PMID 31100118›Full record

ArticleThe Journal of infectious diseases2019

Characterization of Pneumocystis murina Bgl2, an Endo-β-1,3-Glucanase and Glucanosyltransferase.

Geetha Kutty, A Sally Davis, Kaitlynn Schuck, Mya Masterson, Honghui Wang, Yueqin Liu, Joseph A Kovacs

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Targeting β-glucans, vital components of theFrontiers in immunology · 2023
    Review
  3. Characterization ofCell surface (Amsterdam, Netherlands) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Geetha KuttyCritical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland.
A Sally DavisDiagnostic Medicine/Pathobiology, Kansas State University College of Veterinary Medicine, Manhattan.
Kaitlynn SchuckDiagnostic Medicine/Pathobiology, Kansas State University College of Veterinary Medicine, Manhattan.
Mya MastersonDiagnostic Medicine/Pathobiology, Kansas State University College of Veterinary Medicine, Manhattan.
Honghui WangCritical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland.
Yueqin LiuCritical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland.
Joseph A KovacsCritical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, Maryland.
National Institutes of Health Clinical Center · USKansas State University · US

Funding

Molecular Studies Of Human Pneumocystis CariniiZIACL000192 · CLC · CLINICAL CENTER · PI KOVACS, JOSEPH A · 2009 to 2025
$0k
6 · The paper itself

Abstract

Glucan is the major cell wall component of Pneumocystis cysts. In the current study, we have characterized Pneumocystis Bgl2 (EC 3.2.1.58), an enzyme with glucanosyltransferase and β-1,3 endoglucanase activity in other fungi. Pneumocystis murina, Pneumocystis carinii, and Pneumocystis jirovecii bgl2 complementary DNA sequences encode proteins of 437, 447, and 408 amino acids, respectively. Recombinant P. murina Bgl2 expressed in COS-1 cells demonstrated β-glucanase activity, as shown by degradation of the cell wall of Pneumocystis cysts. It also cleaved reduced laminaripentaose and transferred oligosaccharides, resulting in polymers of 6 and 7 glucan residues, demonstrating glucanosyltransferase activity. Surprisingly, confocal immunofluorescence analysis of P. murina-infected mouse lung sections using an antibody against recombinant Bgl2 showed that the native protein is localized primarily to the trophic form of Pneumocystis in both untreated mice and mice treated with caspofungin, an antifungal drug that inhibits β-1,3-glucan synthase. Thus, like other fungi, Bgl2 of Pneumocystis has both endoglucanase and glucanosyltransferase activities. Given that it is expressed primarily in trophic forms, further studies are needed to better understand its role in the biology of Pneumocystis.

Indexed as

Amino Acid SequenceAnimalsAntifungal AgentsCaspofunginCD40 LigandCell WallChlorocebus aethiopsCOS CellsGlucan Endo-1,3-beta-D-GlucosidaseGlucansLungMiceMice, Inbred C57BLMice, KnockoutPneumocystisPneumonia, PneumocystisAntifungal AgentsCaspofunginCD40 LigandGlucan Endo-1,3-beta-D-GlucosidaseGlucansRecombinant ProteinsBgl2cell wallendoglucanaseglucanglucanosyltransferasePneumocystisβ-1

Identifiers

PMID31100118
PMCPMC6941498
OpenAlexW2939121492

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.